All posts by: Michael Zand

Editorial Article: T Cell Engineering for Breakthrough Immunotherapy Research – SelectScience

SelectScienceEditorial Article: T Cell Engineering for Breakthrough Immunotherapy ResearchSelectScienceImmunotherapy is one of the most exciting areas of cancer research today. Metastatic cancer, in particular, remains particularly challenging, as a sy… Continue reading

Editorial Article: T Cell Engineering for Breakthrough Immunotherapy Research – SelectScience

SelectScienceEditorial Article: T Cell Engineering for Breakthrough Immunotherapy ResearchSelectScienceThe preparation of CAR T cells for clinical application is a complex process, not least because national and international legislation and regulation… Continue reading

Ben-Gurion University researcher may have found a treatment to cure leukemia – JerusalemOnline

JerusalemOnlineBen-Gurion University researcher may have found a treatment to cure leukemiaJerusalemOnlineA medical researcher at Ben-Gurion University of the Negev believes that an innovative and targeted form of stem cell treatments might hold the pr… Continue reading

Ben-Gurion University researcher may have found a treatment to cure leukemia – JerusalemOnline

JerusalemOnlineBen-Gurion University researcher may have found a treatment to cure leukemiaJerusalemOnlineA medical researcher at Ben-Gurion University of the Negev believes that an innovative and targeted form of stem cell treatments might hold the pr… Continue reading

WideCells Launches Stem Cell Insurance In Brazil With Storage Facility – Interactive Investor

Proactive Investors UKWideCells Launches Stem Cell Insurance In Brazil With Storage FacilityInteractive InvestorLONDON (Alliance News) – WideCells Group PLC said Tuesday it has signed an agreement for its stem cell healthcare insurance to be offered to… Continue reading

Miltenyi Car T Cell Engineering for Immunotherapy Research – SelectScience